Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Accuray wins Japanese approval for expanded use of CyberKnife system
This regulatory approval expands the types of patients that can be treated with radiosurgery. As a result of this approval, the CyberKnife system may be used in Japan
This regulatory approval expands the types of patients that can be treated with radiosurgery. As a result of this approval, the CyberKnife system may be used in Japan
This trial is a 14-patient, single-arm, open-label, dose-targeted, non-randomized trial of Reolysin given intravenously in combination with a standard dosage of paclitaxel and carboplatin. Eligible patients include those
Under the terms of this agreement, Hisamitsu will obtain a manufacturing and sales approval for the product, and the two companies will subsequently carry out joint sales activities.
As per the FDA’s special protocol assessment process, the study was powered to detect an 8% reduction in visceral adipose tissue (VAT) versus placebo. The study met its
The AB Biodisk product portfolio is said to be very complementary to bioMerieux’s culture media and automated Vitek range for antibiotic susceptibility testing. The addition of the Etest
Pursuant to the terms of the license agreement, Nile will pay development milestones and royalties based on sales of the licensed product. CU-NP was designed by researchers at
The new approvals bring the total number of China Sky One’s externally used products to 53 and its total marketed products to 102, giving the company one of
The initial study will evaluate the safety, tolerability, and the potential of INO-8875 to lower intraocular pressure (IOP) in glaucoma patients. Glaucoma patients typically have elevated levels of
Impulse Monitoring (IMI) will provide Emory-Adventist with comprehensive intraoperative neuromonitoring (IONM) services including IMI-qualified neurophysiologists and real-time professional oversight by an experienced physician. IONM assesses neurological function involving
Under the agreement, Bionomics will receive an upfront payment of $2 million and committed research funding. Merck Serono will fund all development activities, including clinical development. Merck Serono